Core Viewpoint - The company has successfully developed and validated two innovative topical active ingredients for hair loss prevention and regrowth, leveraging its industry-leading AI molecular discovery platform, addressing a growing global market of over 2.5 billion people suffering from hair loss [1] Group 1: Product Development - The two active ingredients developed are small molecule Remeanagen™ (XTP-118) and peptide AquaKine™ (XTP-016) [1] - The combination of these "twin star" molecules has shown significant improvements in hair regrowth and prevention efficacy, safety, and onset speed compared to existing products [1] - Both molecules have successfully passed the INCI registration in the United States, and the combined product Groland has received FDA cosmetic registration [1] Group 2: Market Potential - The global hair loss population is over 2.5 billion and continues to grow, indicating a substantial market opportunity for effective products [1] - The company's AI platform is now entering the consumer health sector, which has significant potential for growth alongside its ongoing drug development for major diseases [1]
晶泰控股(02228.HK)：生发“双子星”新分子获关键国际认证